RECURRENT LUNG NEUROENDOCRINE NEOPLASM

Clinical trials for RECURRENT LUNG NEUROENDOCRINE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new RECURRENT LUNG NEUROENDOCRINE NEOPLASM trials appear

Sign up with your email to follow new studies for RECURRENT LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted radiation vs. standard pill: new hope for advanced lung carcinoid tumors

Disease control Recruiting now

This study is testing whether a new targeted radiation treatment is better than a standard pill at controlling advanced lung neuroendocrine tumors (also called carcinoid tumors). The new treatment, called lutetium Lu 177 dotatate, is an IV drug that seeks out and delivers radiati…

Matched conditions: RECURRENT LUNG NEUROENDOCRINE NEOPLASM

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RECURRENT LUNG NEUROENDOCRINE NEOPLASM

Get alerted when new RECURRENT LUNG NEUROENDOCRINE NEOPLASM trials appear

Targeted radiation vs. standard pill: new hope for advanced lung carcinoid tumors